International Stem Cell Corporation is a biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. Parthenogenesis, the company’s core technology, creates pluripotent human stem cells from unfertilized oocytes – sidestepping the ethical issues associated with using or destroying viable human embryos. hpSCs offer the potential to create UniStemCell, the first true stem cell bank. For more information, visit the company’s Web site at www.internationalstemcell.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: